VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹69 Cr | ₹60 Cr | ₹60 Cr | ₹62 Cr | ₹54 Cr |
What is the latest Operating Profit of VENUS REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹69 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹54 Cr |
How is Operating Profit of VENUS REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹69 Cr | 14.99 | |
| Mar2025 | ₹60 Cr | -0.71 | |
| Mar2024 | ₹60 Cr | -3.36 | |
| Mar2023 | ₹62 Cr | 15.50 | |
| Mar2022 | ₹54 Cr | - | |
Compare Operating Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,263.6 Cr | 1.6% | 8.1% | 271.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 1.6% |
8.1% |
271.3% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses